Cookies
We use cookies to enhance our website and products. By using our website you consent to our use of cookies and similar technologies. Click here to learn more.

Intrommune Therapeutics, Inc.

You've been invited to Invest in Intrommune Therapeutics, Inc..

Investment Details
Deal Intrommune 506c
Issuer Intrommune Therapeutics, Inc.
Offering Common Shares at USD$3.00

Begin Investing

  1. Accept your invitation by entering your email address below and clicking Accept Invitation
  2. You will be shown your Dashboard, where you can begin your investment in Intrommune Therapeutics, Inc.
  3. Create a password to secure your investment information and track your ongoing investments on our secure, online platform.

Intrommune Therapeutics Inc. is conducting a 506c offering, which means all US investors need to (i) qualify as an accredited investor and (ii) provide documentation which can verify this status. If applicable, you will be prompted to provide these documents after signing/funding your agreement. Non-US based investors are welcome to invest and the issuer will assess requirements and eligibility to participate based on local laws. Failure to do so will result in rejection from the offering.

If you already have an account on www.dealmaker.tech, make sure to enter the associated email address and we'll add this investment to your Dashboard when you accept.